Glycated albumin induces activation of activator protein-1 in retinal glial cells.
Okumura
Akinori
A
Mitamura
Yoshinori
Y
Namekata
Kazuhiko
K
Nakamura
Kazuaki
K
Harada
Chikako
C
Harada
Takayuki
T
D000818:Animals; D015153:Blotting, Western; D002478:Cells, Cultured; D003930:Diabetic Retinopathy / Q000150:complications / Q000378:metabolism* / Q000473:pathology; D004195:Disease Models, Animal; D018450:Disease Progression; D004591:Electrophoresis, Polyacrylamide Gel; D005786:Gene Expression Regulation / Q000187:drug effects; D017127:Glycation End Products, Advanced; D006031:Glycosylation; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced / Q000150:complications / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D009457:Neuroglia / Q000378:metabolism* / Q000473:pathology; D012333:RNA, Messenger / Q000235:genetics; D012709:Serum Albumin / Q000494:pharmacology*; D018808:Transcription Factor AP-1 / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D018630:Vitreoretinopathy, Proliferative / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D000093423:Glycated Serum Albumin
D017127:Glycation End Products, Advanced; D012333:RNA, Messenger; D012709:Serum Albumin; D018808:Transcription Factor AP-1; D000093423:Glycated Serum Albumin